The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy
Authors:
Open Access
- 30 October 2024
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 79, 103829
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Netherlands Organisation for Health Research and Development (10330032010001)
This publication has 44 references indexed in Scilit:
- Utilization of neoadjuvant chemotherapy in high‐risk, node‐negative early breast cancerCancer Medicine, 2022
- The association of socioeconomic status on treatment strategy in patients with stage I and II breast cancer in the NetherlandsBreast Cancer Research and Treatment, 2021
- Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017International Journal of Cancer, 2020
- Graphical calibration curves and the integrated calibration index (ICI) for survival modelsStatistics in Medicine, 2020
- Ten‐year recurrence rates for breast cancer subtypes in the Netherlands: A large population‐based studyInternational Journal of Cancer, 2018
- Socioeconomic status and breast cancer treatmentBreast Cancer Research and Treatment, 2017
- Corrected ROC analysis for misclassified binary outcomesStatistics in Medicine, 2017
- Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patientsBreast Cancer Research and Treatment, 2015
- General Aspects of Fitting Regression Models2015
- Tutorial in biostatistics: competing risks and multi‐state modelsStatistics in Medicine, 2006